MétaCan
Menu
Back to cohort
Record W4414621098 · doi:10.1016/j.kint.2025.09.016

Changing paradigms of studies in kidney diseases

2025· article· en· W4414621098 on OpenAlexaff
Adeera Levin, Dustin J. Little, Jane O. Schell, Jennifer S. Lees, Kai‐Uwe Eckardt, Kevin P. Weinfurt, Matthias Rose, Meg Jardine, Morgan E. Grams, Patrick Schloemer, Rathika Krishnasamy, Smeeta Sinha, Fergus Caskey, Masaomi Nangaku, David C. Wheeler, Louise Oni, Jaquelyne T. Hughes, Bill Wang, Charles Cook, Duane Sunwold, Jocelyn Jones, Kate Chong, Thomas Ng, Jo‐Ann Donner, Sandrine Damster, Charu Malik, Hiddo J.L. Heerspink, Agnes B. Fogo, A Gábor, Aminu K. Bello, Andrea K. Viecelli, Brendon L. Neuen, Chi‐yuan Hsu, Cory James Williams, David Platt, Elena Babak, Elena Zakharova, Eyler Ngoh Ndumeya, Glenn M. Chertow, Ian H. de Boer, Ivan Rychlik, Jay Elliott, Jennifer A. McKenzie, Jonathan Barratt, Katherine R. Tuttle, Kirsten L. Johansen, Liz Lightstone, Maarten W. Taal, Magdalena Madero, Marcello Tonelli, Martin H. de Borst, Matthew T. James, Matthias Kretzler, Meike Brinker, Mototsugu TANAKA, Navdeep Tangri, Niels Jongs, Parminder K. Judge, Patrick B. Mark, Rolando Claure-Del Granado, Rümeyza Kazancıoğlu, Sunita Bavanandan, Sushrut S. Waikar, Thomas Idorn, Tom Greene, Wolfgang C. Winkelmayer­

Bibliographic record

VenueKidney International · 2025
Typearticle
Languageen
FieldMedicine
TopicChronic Kidney Disease and Diabetes
Canadian institutionsKidney Foundation of CanadaUniversity of British ColumbiaProvidence Health Care
FundersNovo NordiskInternational Society of NephrologyAlexion PharmaceuticalsAstraZenecaAmgen
KeywordsNephrologyClinical trialKidney diseaseBiomarkerMEDLINEDiversity (politics)Resource (disambiguation)Global health

Abstract

fetched live from OpenAlex

Recognizing kidney disease as a major global health issue, the International Society of Nephrology convened a 2-day international, multi-stakeholder meeting to develop a road map for advancing clinical research in nephrology. The meeting focused on promoting the use of patient-reported outcome measures, moving beyond single biomarker targets, adopting innovative trial designs, and incorporating hierarchical composite end points. Participants included clinicians, trialists, regulators, patient partners, and industry experts invited from all International Society of Nephrology regions. Discussions emphasized the importance of inclusive trial design, validation of patient-reported outcome measures, predictive enrichment strategies, and broader trial accessibility across resource settings. Key recommendations included enhancing diversity in trial populations, avoiding overreliance on isolated biomarkers, adopting novel study designs, strengthening public-private partnerships, and validating composite end points. A coordinated effort was deemed essential to implement these strategies in both research and practice, ensuring sustainable progress and reducing the global burden of kidney disease.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.631
metaresearch head score (Gemma)0.492
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.631
Threshold uncertainty score0.455

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.6310.492
Meta-epidemiology (narrow)0.0030.003
Meta-epidemiology (broad)0.0080.005
Bibliometrics0.0190.008
Science and technology studies0.0100.151
Scholarly communication0.0400.062
Open science0.0160.032
Research integrity0.0190.073
Insufficient payload (model declined to judge)0.0050.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.024
GPT teacher head0.350
Teacher spread0.327 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueKidney InternationalSame topicChronic Kidney Disease and DiabetesFrench-language works237,207